Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1)

Francis B Panosyan, Matilde Laura, Alexander M Rossor, Chiara Pisciotta, Giuseppe Piscosquito, Joshua Burns, Jun Li, Sabrina W Yum, Richard A Lewis, John Day, Rita Horvath, David N Herrmann, Michael E Shy, Davide Pareyson, Mary M Reilly, Steven S Scherer, Inherited Neuropathies Consortium—Rare Diseases Clinical Research Network (INC-RDCRN), Richard Lewis, John Day, Gyula Acsadi, Mario Saporta, Stephan Züchner, Richard Finkel, Michael Shy, Shawna Feely, Thomas Lloyd, Vera Fridman, Sindhu Ramchandren, David Walk, David Herrmann, Erig Logigian, Michael Stanton, Katy Eichinger, Debra Guntrum, Cindy Gibson, Steven Scherer, Sabrina Yum, Jun Li, Joshua Burns, Davide Pareyson, Isabella Moroni, Chiara Pisciotta, Mary Reilly, Matilde Laurá, Francesco Muntoni, Francis B Panosyan, Matilde Laura, Alexander M Rossor, Chiara Pisciotta, Giuseppe Piscosquito, Joshua Burns, Jun Li, Sabrina W Yum, Richard A Lewis, John Day, Rita Horvath, David N Herrmann, Michael E Shy, Davide Pareyson, Mary M Reilly, Steven S Scherer, Inherited Neuropathies Consortium—Rare Diseases Clinical Research Network (INC-RDCRN), Richard Lewis, John Day, Gyula Acsadi, Mario Saporta, Stephan Züchner, Richard Finkel, Michael Shy, Shawna Feely, Thomas Lloyd, Vera Fridman, Sindhu Ramchandren, David Walk, David Herrmann, Erig Logigian, Michael Stanton, Katy Eichinger, Debra Guntrum, Cindy Gibson, Steven Scherer, Sabrina Yum, Jun Li, Joshua Burns, Davide Pareyson, Isabella Moroni, Chiara Pisciotta, Mary Reilly, Matilde Laurá, Francesco Muntoni

Abstract

Objective: To extend the phenotypic description of Charcot-Marie-Tooth disease (CMTX1) and to draw new genotype-phenotype relationships.

Methods: Mutations in GJB1 cause the main X-linked form of CMTX (CMTX1). We report cross-sectional data from 160 patients (from 120 different families, with 89 different mutations) seen at the Inherited Neuropathies Consortium centers.

Results: We evaluated 87 males who had a mean age of 41 years (range 10-78 years) and 73 females who had a mean age of 46 years (range 15-84 years). Sensory-motor polyneuropathy affects both sexes, more severely in males than in females, and there was a strong correlation between age and disease burden in males but not in females. Compared with females, males had more severe reduction in motor and sensory neurophysiology parameters. In contrast to females, the radial nerve sensory response in older males tended to be more severely affected compared with younger males. Median and ulnar nerve motor amplitudes were also more severely affected in older males, whereas ulnar nerve motor potentials tended to be more affected in older females. Conversely, there were no statistical differences between the sexes in other features of the disease, such as problems with balance and hand dexterity.

Conclusions: In the absence of a phenotypic correlation with specific GJB1 mutations, sex-specific distinctions and clinically relevant attributes need to be incorporated into the measurements for clinical trials in people with CMTX1.

Clinicaltrialsgov identifier: NCT01193075.

Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Figures

Figure 1. Amino acid sequence and reported…
Figure 1. Amino acid sequence and reported GJB1 mutations
Schematic diagram showing the predicted amino acid sequence and all 420 reported GJB1 mutations (Inherited Neuropathies Consortium variant Browser [hihg.med.miami.edu/code/http/cmt/public_html/index.html#/]). Previously unreported mutations reported are shown in red.
Figure 2. Age, sex, and clinical characteristics…
Figure 2. Age, sex, and clinical characteristics of patients with CMTX1 in the cohort
(A) Frequency distribution of age and sex of patients with CMTX1 at the age they were first given a CMTNS in an Inherited Neuropathies Consortium clinic. (B) Clinical characteristics separated by sex of 160 patients with CMTX1. CMTX1 = X-linked form of Charcot-Marie-Tooth disease.
Figure 3. CMT examination score and CMT…
Figure 3. CMT examination score and CMT neuropathy score in male patients with CMTX1
(A) CMTES and CMTNS in male patients with CMTX1 grouped by age. The CMTES is based on history and neurologic examination; the CMTNS adds neurophysiology. Both CMTES and CMTNS increase with age in male patients with CMTX1 (p < 0.0005 for both CMTES and CMTNS, analysis of variance). (B) CMTES and CMTNS in female patients with CMTX1 grouped by age. There is an increase in CMTES (but not CMTNS) after the second decade (p < 0.03, analysis of variance). CMTES = Charcot-Marie-Tooth disease examination score; CMTNS = Charcot-Marie-Tooth disease neuropathy score; CMTX1 = X-linked form of Charcot-Marie-Tooth disease.
Figure 4. Nerve conduction studies in male…
Figure 4. Nerve conduction studies in male and female patients with CMTX1 according to age
(A) Ulnar and median nerve CMAPs in males and females with CMTX1 by age. The data from individual patients are represented as single points. There is a correlation between the ulnar and median CMAP with age in males (p = 0.02, Spearman ρ = −0.4, and p = 0.002, Spearman ρ = −0.6, respectively) and ulnar CMAP with age in females (p = 0.002, Spearman ρ = −0.6). A correlation is not observed between median CMAP with age in females (p = 0.3, Spearman ρ = −0.2). (B) Ulnar and median motor NCVs in males and females with CMTX1 by age. The data from individual patients are represented as single points. Nerves that did not have a recordable response were excluded. A correlation is not observed between ulnar and median motor NCVs in males with age (p = 0.8 and 0.2, Spearman ρ = 0.04 and 0.30, respectively). A correlation is also not observed between ulnar and median motor NCVs in females with age (p = 0.7 and 0.4, Spearman ρ = 0.06 and 0.10, respectively). (C) Amplitude of the ulnar and radial SNAPs in males and females with CMTX1 by age. The data from individual patients are represented as single points. There is a correlation between the radial sensory SNAPs with age in males (p = 0.01, Spearman ρ = −0.4). A correlation is not observed between ulnar sensory SNAPs with age in males (p = 0.6, Spearman ρ = −0.1). A correlation is also not observed between ulnar and radial SNAPs with age in females (p = 0.8 and 0.9, Spearman ρ = 0.04 and 0.01, respectively). CMAP = compound muscle action potential; CMTX1 = X-linked form of Charcot-Marie-Tooth disease; MNCV = motor nerve conduction velocity; SNAP = sensory nerve action potential.

References

    1. Fridman V, Bundy B, Reilly MM, et al. . CMT subtypes and disease burden in patients enrolled in the INC natural history study (6601) from 2009 to 2013. J Neurol Neurosurg Psychiatry 2015;86:873–878.
    1. Bergoffen J, Scherer SS, Wang S, et al. . Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993;262:2039–2042.
    1. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 1996;238:1–27.
    1. Balice-Gordon RJ, Bone LJ, Scherer SS. Functional gap junctions in the Schwann cell myelin sheath. J Cell Biol 1998;142:1095–1104.
    1. Tomaselli PJ, Rossor AM, Horga A, et al. . Mutations in non-coding regions of GJB1 are a major cause of X-linked CMT. Neurology 2017;88:1445–1453.
    1. Kleopa KA, Abrams CK, Scherer SS. How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease? Brain Res 2012;1487:198–205.
    1. Shy ME, Siskind C, Swan ER, et al. . CMT1X phenotypes represent loss of GJB1 gene function. Neurology 2007;68:849–855.
    1. Rozear MP, Pericakvance MA, Fischbeck K, et al. . Hereditary motor and sensory neuropathy, X-linked—a half century follow-up. Neurology 1987;37:1460–1465.
    1. Hahn AF. Hereditary motor and sensory neuropathy—HMSN type-II (neuronal type) and X-linked HMSN. Brain Pathol 1993;3:147–155.
    1. Nicholson G, Nash J. Intermediate nerve-conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 1993;43:2558–2564.
    1. Hahn AF, Bolton CF, White CM, et al. . Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease. Ann N Y Acad Sci 1999;883:366–382.
    1. Dubourg O, Tardieu S, Birouk N, et al. . Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. Brain 2001;124:1958–1967.
    1. Siskind CE, Murphy SM, Ovens R, Polke J, Reilly MM, Shy ME. Phenotype expression in women with CMT1X. J Peripher Nerv Syst 2011;16:102–107.
    1. Scherer SS, Xu YT, Nelles E, Fischbeck K, Willecke K, Bone LJ. Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 1998;24:8–20.
    1. Shy ME, Blake J, Krajewski K, et al. . Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005;64:1209–1214.
    1. Murphy SM, Herrmann DN, McDermott MP, et al. . Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2011;16:191–198.
    1. Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 2013;111:52–58.
    1. Birouk N, Le Guern E, Maisonobe T, et al. . X-linked Charcot-Marie-Tooth disease with connexin 32 mutations—clinical and electrophysiological study. Neurology 1998;50:1074–1082.
    1. Arthur-Farraj PJ, Murphy SM, Laura M, et al. . Hand weakness in Charcot-Marie-Tooth disease 1X. Neuromuscul Disord 2012;22:622–626.
    1. Ekins S, Litterman NK, Arnold RJG, et al. . A brief review of recent Charcot-Marie-Tooth research and priorities. F1000Res 2015;4:53.
    1. Klein D, Patzko A, Schreiber D, et al. . Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Brain 2015;138:3193–3205.
    1. Kagiava A, Sargiannidou I, Theophilidis G, et al. . Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy. Proc Natl Acad Sci USA 2016;113:E2421–E2429.

Source: PubMed

Подписаться